Date & Time: Wednesday, February 23, 2022 2:00 pm ET
Wendi Mader, Executive Director, Enterprise and Employer Population Health, Quest Diagnostics
Dr. Steven Goldberg, Vice President, Chief Health Officer, Medical Affairs, Diagnostic Services, New Ventures, Quest Diagnostics
Employees have deferred routine care due to COVID-19. In fact, there was an estimated 70% decrease in doctor’s visits during the pandemic, and nearly 1 in 3 Americans who have a chronic medical condition say that their condition has worsened since the pandemic began. Prior to the pandemic 74% of large employers sponsored yearly biometric screenings, but COVID-19 has changed the business landscape from a primarily on-site to remote work environment. This has caused some employers to pause traditional on-site programs like biometric screenings.¹
The combination of employees deferring care and employers pausing well-being programs has created a significant risk for chronic disease progression. In this everchanging work environment, do employer-sponsored screening programs play a role in decreasing incidences of chronic conditions? And can a traditional, one-size-fits-all screening program be effective in the new normal of America’s workforce?
Quest Diagnostics works with thousands of employers nationwide to help improve employee health. Join this webinar to hear experts from Quest Diagnostics discuss the impact deferred care is having on America’s workforce according to laboratory data and find out if clinical screening insights move the needle when it comes to health improvement.
¹12th Annual Employer Sponsored Health & Well-Being Survey: Fidelity and the National Business Group on Health (2021) N = 166